Plasma symmetric dimethylarginine as a metabolite biomarker of severe acute ischemic stroke

IntroductionAfter severe ischemic stroke (IS), circulating levels of symmetric dimethylarginine (SDMA) increase. We investigated the early dynamics of SDMA in stroke to potentially aid with prehospital identification of severe IS from hemorrhagic stroke (HS).MethodsWe performed targeted mass spectro...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Saana Pihlasviita, Olli S. Mattila, Tiina Nukarinen, Markku Kuisma, Heini Harve-Rytsälä, Juhani Ritvonen, Gerli Sibolt, Sami Curtze, Daniel Strbian, Mikko Pystynen, Turgut Tatlisumak, Perttu J. Lindsberg
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-11-01
Serie:	Frontiers in Neurology
Soggetti:	stroke diagnosis acute management biomarkers SDMA
Accesso online:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1472424/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!